CYTOKINETICS INC financial data

Symbol
CYTK on Nasdaq
Location
South San Francisco, CA
Fiscal year end
31 December
Latest financial report
26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 588% % -26%
Debt-to-equity -395% % 69%
Return On Equity 173% % -68%
Return On Assets -59% % -29%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 123,162,807 shares 4%
Common Stock, Shares, Outstanding 122,943,172 shares 4%
Entity Public Float $2,500,000,000 USD -55%
Common Stock, Value, Issued $123,000 USD 4.2%
Weighted Average Number of Shares Outstanding, Basic 120,103 shares 7.3%
Weighted Average Number of Shares Outstanding, Diluted 120,103 shares 7.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $88,039,000 USD 377%
Research and Development Expense $416,026,000 USD 23%
General and Administrative Expense $284,271,000 USD 32%
Operating Income (Loss) $612,258,000 USD -14%
Nonoperating Income (Expense) $48,420,000 USD -6%
Net Income (Loss) Attributable to Parent $784,955,000 USD -33%
Earnings Per Share, Basic -6.54 USD/shares -24%
Earnings Per Share, Diluted -6.54 USD/shares -24%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $122,518,000 USD 29%
Cash, Cash Equivalents, and Short-term Investments $1,200,000,000 USD 0%
Accounts Receivable, after Allowance for Credit Loss, Current $17,764,000 USD 6.7%
Assets, Current $916,975,000 USD -17%
Property, Plant and Equipment, Net $79,194,000 USD 20%
Operating Lease, Right-of-Use Asset $75,979,000 USD 1.1%
Other Assets, Noncurrent $17,341,000 USD 125%
Assets $1,424,537,000 USD 1.6%
Accounts Payable, Current $22,337,000 USD 9.7%
Employee-related Liabilities, Current $45,150,000 USD 29%
Accrued Liabilities, Current $83,278,000 USD 51%
Liabilities, Current $202,452,000 USD 13%
Operating Lease, Liability, Noncurrent $107,970,000 USD -4.1%
Other Liabilities, Noncurrent $1,612,000 USD
Liabilities $2,084,162,000 USD 36%
Accumulated Other Comprehensive Income (Loss), Net of Tax $630,000 USD -74%
Retained Earnings (Accumulated Deficit) $3,486,719,000 USD -29%
Stockholders' Equity Attributable to Parent $659,625,000 USD -387%
Liabilities and Equity $1,424,537,000 USD 1.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $131,617,000 USD -1.6%
Net Cash Provided by (Used in) Financing Activities $4,754,000 USD -95%
Net Cash Provided by (Used in) Investing Activities $105,956,000 USD 225%
Common Stock, Shares Authorized 326,000,000 shares 0%
Common Stock, Shares, Issued 122,943,172 shares 4%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $21,177,000 USD -405%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $125,632,000 USD 32%
Interest Paid, Excluding Capitalized Interest, Operating Activities $9,647,000 USD -5.5%
Deferred Tax Assets, Valuation Allowance $858,902,000 USD 20%
Deferred Tax Assets, Gross $879,744,000 USD 20%
Operating Lease, Liability $127,081,000 USD -3.4%
Payments to Acquire Property, Plant, and Equipment $5,664,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $786,723,000 USD -34%
Lessee, Operating Lease, Liability, to be Paid $176,961,000 USD -7.3%
Property, Plant and Equipment, Gross $126,495,000 USD 23%
Operating Lease, Liability, Current $19,111,000 USD 0.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two $22,171,000 USD 9.9%
Lessee, Operating Lease, Liability, to be Paid, Year One $20,096,000 USD 2.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $49,880,000 USD -16%
Lessee, Operating Lease, Liability, to be Paid, Year Three $22,828,000 USD 11%
Deferred Tax Assets, Operating Loss Carryforwards $498,689,000 USD 76%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $35,945,000 USD 16%
Lessee, Operating Lease, Liability, to be Paid, Year Four $22,908,000 USD 10%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $2,300,000 USD -1.3%
Share-based Payment Arrangement, Expense $112,286,000 USD 15%
Interest Expense $11,353,000 USD 27%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%